NAPSRX CH. 21 TERMINOLOGY QUESTIONS AND ANSWERS WITH SOLUTIONS 2024

NAPSRX CH. 21 TERMINOLOGY
QUESTIONS AND ANSWERS WITH
SOLUTIONS 2024
A.A.G-GANSWERGofGeach

-referringGtoGmedicationGdosage



A.C.G-GANSWERGbeforeGmeals

-referringGtoGmedicationGdosage



AAHPG(AmericanGAssociationGofGHealthGPlans)G-
GANSWERGtheGprimaryGU.S.GassociationGofGhealthGplans,GwhichGincludesGhealthGmaintenanceGorganization

sG(HMOs),GpreferredGproviderGorganizationsG(PPOs),GotherGformsGofGmanagedGcare,GandGutilizationGreview
GorganizationsG(UROs)




AbsorptionGRateG-
GANSWERGtheGamountGofGtimeGitGtakesGaGdrugGtoGenterGaGperson'sGbloodstreamGwithinGaGspecifiedGperiod



-
canGvaryGfromGpersonGtoGpersonGcreatingGaGchallengeGofGrefiningGaGdrugGsoGthatGitGisGeffectiveGforGtheGlow
Gside,GbutGnotGtoxicGtoGpeopleGonGtheGhighGside




AbsorptionG-GANSWERGtheGprocessGinGwhichGaGmedicationGentersGtheGbloodstream



ACG-GANSWERGanticholinergicGsideGeffectsG(dryGmouth,GblurredGvision,GandGurinaryGretention)



ACG-GANSWERGanticholinergicGsideGeffectsG(dryGmouth,GblurredGvision,GandGurinaryGretention)



ACEGInhibitorsG-GANSWERGangiotensin-convertingGenzymeGinhibitors

-treatsGcardiovascularGconditionsGsuchGasGhypertensionGandGchronicGheartGfailure

-pril's

,ActionGLetterG-GANSWERGtheGFDA'sGofficialGresponseGtoGanGNDA

-akaGNDAGAction

-messageGmayGbeGapproval,Gapprovable,GorGnon-approvable



ActiveGMetaboliteG-GANSWERGAGbiologicalGactiveGproductGofGaGmedication'sGmetabolism



AcuteGIllnessG-GANSWERGaGconditionGthatGonlyGlastsGaGshortGperiodGofGtime

-example,GtheGcommonGcold



AcuteG-GANSWERGinGtermsGofGdiseasesGandGconditions,GabruptGinGonsetGandGshort-term



Ad.GLibG-GANSWERGfreely

-referringGtoGmedicationGdosage



AdditionsG-
GANSWERGsituationsGwhereGtwoGorGmoreGmedicationsGareGusedGtogetherGandGtheGclinicalGeffectGisGequalGt

oGtheGsumGofGtheirGindividualGeffects



AdherenceG-GANSWERGtheGproperGuseGofGaGmedicationGbyGaGpatient

-takingGmedicationGonGcorrectGscheduleGoutlinedGbyGaGphysician,GandGusingGproperGtechnique



AdjuvantG-GANSWERGaGsubstanceGthatGenhancesGtheGactionGofGaGdrugGorGantigen.

-____therapyGisGtheGuseGofGaGsecondGformGofGtreatmentGinGadditionGtoGtheGprimaryGtherapyG

e.g.GhavingGchemotherapyGinGadditionGtoGsurgeryGorGradiationGtherapy



ADMEG-GANSWERGabsorption,Gdistribution,Gmetabolism,Gexcretion

-testGperformedGtoGassessGtheGimpactGofGaGdrugGonGtheGhumanGbodyG(pharmacokinetics)G

-
theGidealGproductGwillGbeGrapidlyGabsorbed,GdistributedGtoGtheGtargetGorgan,GbrokenGdownGefficientlyGwit
houtGgeneratingGanyGtoxicGsubstances,GandGexcretedGeffectivelyGfromGtheGbodyGwithoutGharmingGtheGkidn
eysGorGotherGorgans

,AdverseGDrugGReactionG-
GANSWERGanGunwanted,GnegativeGconsequenceGsometimesGassociatedGwithGtheGuseGofGdrugGtherapy.



-aGmoreGpreciseGtermGthanG'sideGeffect',GasGsomeGsideGeffectsGmayGbeGtherapeuticallyGuseful.



AdverseGEffectG-GANSWERGAnGunwantedGeffectGaGmedicationGmayGhaveGonGaGperson



AdverseGEventG-
GANSWERGAnGunanticipatedGeventGthatGinvolvesGriskGtoGtheGsubjectGandGthatGresultsGinGharmGtoGtheGsubje

ctGorGothers



AFG-GANSWERGatrialGfibrillation



AffinityG-GANSWERGaGmeasureGofGtheGbindingGofGanGantibodyGtoGanGantigen



AgonistG-GANSWERGaGdrugGcapableGofGcombiningGtheGreceptorsGtoGinitiateGdrugGactions



AMAG(AmericanGMedicalGAssociation)G-
GANSWERGaGnationalGassociationGbasedGinGChicagoGthatGrepresentsGmoreGthanG700,000GmedicalGdoctorsGi

nGtheGU.S.G

-
amongGotherGthings,GitGdefinesGethicalGstandardsGthatGphysiciansGshouldGobserveGinGtheirGrelationshipsGw
ithGpharmaceuticalGcompaniesGandGinGtheirGprescribingGbehavior



AlignmentG-
GANSWERGtheGmannerGinGwhichGclientGresponsibilitiesGareGallocatedGamongGsalesGrepsGinGaGpharmaceutic

alGcompany

e.g.GbyGtherapeuticGarea,Ggeography,Gand/orGtheGsalesGpotentialGofGaGgivenGassignment



-althoughGStarkGisGreferredGtoGasGaGlawGagainstGself-
referralG(referralGtoGanGentityGinGwhichGoneGhasGaGfinancialGstake),GitGappliesGmoreGbroadlyGtoGotherGarran
gementsGinGwhichGaGphysicianGisGfinanciallyGrewardedGforGgeneratingGserviceGorGproductGsales.GStarkGIGlim
itedGtheGprohibitionGtoGclinicalGlaboratories.GStarkGIIGextendedGtheGprohibitionGtoGotherG'designatedGhealt
hGservices',GincludingGoutpatientGprescriptionGdrugs

, APhAG(AmericanGPharmaceuticalGAssociation)G-
GANSWERGtheGnationalGprofessionalGsocietyGofGpharmacists,GfoundedGinG1852,GitGwasGtheGfirstGandGisGstillG

theGlargestGprofessionalGassociationGofGpharmacistsGinGtheGU.S.

-
theGmembersGincludeGpracticingGpharmacists,GpharmaceuticalGscientists,GpharmacyGstudents,GandGpharm
acyGtechnicians



AMCPG(AcademyGofGManagedGCareGPharmacy)G-
GANSWERGAnGorganizationGforGpharmacyGdirectors.GItGisGtheGnationalGprofessionalGsocietyGdedicatedGtoGp

harmaceuticalGcareGinGmanagedGhealthcareGenvironments



AmideG-GANSWERGanGorganicGcompoundGcontainingGanG(O-C-N)Ggroup



AminoGAcidG-GANSWERGbuildingGblockGofGpeptides/proteins



AmyloidG-GANSWERGaGglycoproteinGthatGisGdepositedGextracellularlyGinGtissues



AnalgesicG-GANSWERGpainGreliever



AnalogueG-GANSWERGsimilarGinGchemicalGandGphysicalGstructure



AnaphylaxisG-
GANSWERGanGextremeGsensitivityGandGreactionGtoGaGforeignGsubstance,GincludingGmedications




AncillaryGCareG-
GANSWERGSupplementalGhealthGservicesGthatGfacilitateGdiagnosisGandGtreatment,GincludingGlabGworkGandG

x-rays



ANDAG-GANSWERGabbreviatedGnewGdrugGapplication



AndrogenG-GANSWERGaGmaleGspecificGreproductiveGhormone